Vice Provost and Dean of Research
Showing 61-70 of 187 Results
-
Larry John Leifer
Professor of Mechanical Engineering, Emeritus
Current Research and Scholarly InterestsOur "designXlab" at the Stanford Center for Design Research (CDR) has long (30+ years) been focused on Engineering Design Team dynamics at global collaboration scale working with corporate partners in my graduate course ME310ABC. In our most recent studies we have added Neuroscience visualization of brain activity using fMRI and fNIRS. In doing so we have launched "NeuroDesign" as a professional discipline.
-
John Leikauf
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsI am interested in better understanding the heterogeneous cognitive and electrophysiological abnormalities in children with ADHD and the many other conditions that commonly co-occur with ADHD. The long-term goal is to be able to better target treatments to specific deficits in order to promote long-term health and well-being and improve outcomes that matter to individuals and families suffering from these disorders.
-
Sanjiva Lele
Edward C. Wells Professor of the School of Engineering and Professor of Mechanical Engineering
BioProfessor Lele's research combines numerical simulations with modeling to study fundamental unsteady flow phemonema, turbulence, flow instabilities, and flow-generated sound. Recent projects include shock-turbulent boundary layer interactions, supersonic jet noise, wind turbine aeroacoustics, wind farm modeling, aircraft contrails, multi-material mixing and multi-phase flows involving cavitation. He is also interested in developing high-fidelity computational methods for engineering applications.
-
Anna Lembke, MD
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
BioDr. Anna Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She is currently Professor and Medical Director of Addiction Medicine, Stanford University School of Medicine. She is also Program Director of the Stanford Addiction Medicine Fellowship, Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic, and a diplomate of the American Board of Psychiatry and Neurology and the American Board of Addiction Medicine.
In 2016, she published "Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop" (Johns Hopkins University Press, 2016), highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018).
Dr. Lembke appeared in the Netflix documentary The Social Dilemma, an unvarnished look at the impact of social media on our lives.
Her latest book, "Dopamine Nation: Finding Balance in the Age of Indulgence" (Dutton/Penguin Random House, August 2021) was an instant New York Times and Los Angeles Times bestseller and has been translated into 30 languages. It combines the neuroscience of addiction with the wisdom of recovery to explore the problem of compulsive overconsumption in a dopamine-overloaded world. -
Mark Lemley
William Neukom Professor of Law and Senior Fellow at the Stanford Institute for Economic Policy Research
Current Research and Scholarly Interestsintellectual property, Internet, and antitrust law; law and AI/robotics
-
Theodore Leng, MD, MS, FACS
Professor of Ophthalmology (Ophthalmology Research/Clinical Trials) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsDr. Leng was the first surgeon in California to perform a subretinal transplant of adult neural stem cells into patients with macular degeneration and is actively researching cell and gene regenerative therapies for macular degeneration, retinitis pigmentosa, Stargardt disease, and other degenerative conditions of the macula and retina. He also has an active program in imaging informatics, oculomics, and deep learning to identify patients who are at risk for eye and systemic disease. The end goal is earlier detection and rapid treatment to maximize outcomes.
